UBE2T and hepatocellular carcinoma: In the HCC cell lines HCCLM3, HepG2, Hep3B, and Huh7, miR-1305 restrains CSCs’ self-renewal, and the expression of stem markers, and inhibits the tumorsphere quantity by inhibiting the downstream target, ubiquitin-conjugating enzyme E2T (UBE2T).